PARP inhibitor era in ovarian cancer treatment: a systematic review and meta-analysis of randomized controlled trials
Abstract Background Ovarian cancer is the eighth leading cause of cancer-related death among women, characterized by late diagnosis and a high relapse rate. In randomized controlled trials, we aimed to evaluate the efficacy and safety of PARP inhibitors (PARPi) in treating advanced ovarian cancer. M...
Saved in:
Main Authors: | István Baradács (Author), Brigitta Teutsch (Author), Alex Váradi (Author), Alexandra Bilá (Author), Ádám Vincze (Author), Péter Hegyi (Author), Tamás Fazekas (Author), Balázs Komoróczy (Author), Péter Nyirády (Author), Nándor Ács (Author), Ferenc Bánhidy (Author), Balázs Lintner (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ranking the dietary interventions by their effectiveness in the management of polycystic ovary syndrome: a systematic review and network meta-analysis
by: Anna Evelin Juhász, et al.
Published: (2024) -
Lifestyle-, environmental-, and additional health factors associated with an increased sperm DNA fragmentation: a systematic review and meta-analysis
by: Anett Szabó, et al.
Published: (2023) -
Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
by: Dorina Greff, et al.
Published: (2023) -
Therapeutic Monitoring of Orally Administered, Small-Molecule Anticancer Medications with Tumor-Specific Cellular Protein Targets in Peripheral Fluid Spaces-A Review
by: Zoltán Köllő, et al.
Published: (2023) -
Prevention of Chronic Morbidities in Extremely Premature Newborns with LISA-nCPAP Respiratory Therapy and Adjuvant Perinatal Strategies
by: Gergely Balázs, et al.
Published: (2023)